Integra Connect solutions can accelerate adoption of value-based, precision medicine efforts across the care continuum:

Icon test
Precision Medicine
Solutions for Providers

Deliver high quality patient care and experiences, while managing costs.

Icon test
Integra Connect
Platform

Advance research, improve drug development and maximize revenue.

Icon test
Revenue Cycle Management
Solutions

Boost collections, accelerate the billing process, and find hidden growth potential.

Icon test
Population Health
Solutions

Identify at-risk patients and populations for proactive intervention, optimize costs and quality performance, and excel under value-based payment models.

Icon test
IntegraCloud
EHR

Understand the patient journey, improve work efficiency, integrate care and information flows, and easily analyze and report performance.

Icon test
Precision Medicine Solutions
for Life Sciences

Identify opportunities for clinical research and drug development, support pipeline, and launch medicines for the benefit of patients

How Integra Connectis different

Integra Connect is driven to make specialty care practices clinically and financially successful through value-based, precision medicine. While other companies may focus on one of these areas, Integra Connect’s combined approach means providers, payers, and life sciences companies can harness value-based, precision medicine principles to improve their decision-making and make a difference in patients’ lives.

SCHEDULE A DEMO

Solutions for specialty practices

With advanced predictive analytics, Integra Connect can help providers identify at-risk patients, understand opportunities to optimize quality and cost performance, and drive better treatment decisions for better outcomes. With this focus, providers can be better equipped to excel under value-based care models.

Solutions for health systems

With Integra Connect’s performance analytics, you can understand how to better perform under value-based care models. Our solutions can help you identify quality and cost improvement opportunities, identify at-risk patients and populations for proactive interventions and improved outcomes, as well as optimize revenue cycle performance for your bottom line.

Solutions for payers

With Integra Connect’s Alternative Payment Models (APM) enablement and value-based care solutions, payers can identify savings opportunities, while enabling providers to make optimal treatment decisions at the point of care. Our analytics track providers’ cost and quality performance, analyze treatment patterns and compliance, and risk stratify patients in near-real time for provider intervention.

Solutions for life sciences companies

Integra Connect solutions can provide insight into drug performance like never before. Our insights are based on 100% real-world practice data and the largest financial data set in the industry.

Make data-driven decisions with our Precision Medicine platform

Integra Connect’s precision medicine platform is the industry’s most comprehensive and advanced solution for providing personalized patient care.

LEARN MORE
Precision Medicine Solutions for Oncology Practices

Adopt a targeted, personalized and patient-centered approach to care with the aid of advanced analytics and expert guidance.

Precision Medicine Solutions for Life Sciences Companies

Identify opportunities for drug development, HEOR research, and improved patient outcomes with our industry-leading data services.

Our Leadership

Our leadership team is composed of experts with extensive real-world experience working in clinical settings.

SEE MORE LEADERS

Resources

Best practices for optimising performance under value-based reimbursement models, developed by our in-house experts.

Publications

Access content and gain insights about the role data plays in healthcare transformation and how data can empower informed decisions.

News

See the latest announcements, news and media coverage.

Videos

Watch videos and interviews about the future of healthcare in a value-based ecosystem including quality improvement and much more.

What the Industry is SayingAbout Integra Connect

CISION PR News Wire

Integra Connect Statement on the Enhancing Oncology Model

Integra Connect, LLC. is pleased that the Centers for Medicare & Medicaid Services’ (CMS) Center for Medicare & Medicaid Innovation (CMMI) announced the next iteration of its value-based, oncology care…

Read more
CISION PR News Wire

Integra Connect to Share Study Results Underscoring the Importance of Early and Rapid Genetic Testing for Improved Survival Rates in Patients with Newly Diagnosed, Stage 4 Non-Small Cell Lung Cancer

WEST PALM BEACH, Fla. Integra Connect, the leading provider of value-based, precision medicine solutions and services for specialty care, will present findings from a retrospective observational study in newly diagnosed, stage 4 non-small cell lung cancer (NSCLC) that demonstrates improved patient survival rates when molecular testing is applied prior to initiating treatment. The results will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4 at 1:15 p.m. CST.

Read more
G1 Therapeutics

New real-world data show potential of Trilaciclib to reduce the substantial burden of myelosuppression in patients with extensive-stage small-cell lung cancer treated with chemotherapy

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced results of a retrospective, observational study describing the substantial burden of myelosuppression and its impact on healthcare resource utilization (HCRU) in 3,277 patients being treated with chemotherapy for extensive-stage small-cell lung cancer (ES-SCLC). The study also described patient outcomes from 21 patients receiving trilaciclib prior to chemotherapy; of these, 17 received commercial trilaciclib in the real-world setting, and four received trilaciclib in clinical trials.

Read more